Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

IMNM

Immunome Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • IMNMImmunome, Inc.
    0Calm

    A Study of AL102 in Patients With Progressing Desmoid Tumors

    Running, no new patientsPhase 2/3198 patientsMain results: Dec 3, 2025

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

21 sales (2 not pre-planned) · 4 purchases

  • Higgins JackChief Scientific Officer · Sep 11, 2026Sold 13,200 sharesabout $334 thousand · pre-planned
  • Barchas IsaacBoard member · Aug 12, 2026Sold 11,048 sharesabout $301 thousand · pre-planned
  • Barchas IsaacBoard member · Aug 11, 2026Sold 62,291 sharesabout $1.6 million · pre-planned
  • Barchas IsaacBoard member · Aug 10, 2026Sold 10,125 sharesabout $264 thousand · pre-planned
  • Barchas IsaacBoard member · Aug 7, 2026Sold 15,248 sharesabout $397 thousand · pre-planned
  • Barchas IsaacBoard member · Aug 6, 2026Sold 20,840 sharesabout $543 thousand · pre-planned
  • Horn KinneyCHIEF BUSINESS OFFICER · Aug 4, 2026Sold 90,616 sharesabout $2.3 million · pre-planned
  • Horn KinneyCHIEF BUSINESS OFFICER · Jul 7, 2026Sold 1,092 sharesabout $27 thousand · pre-planned
  • Barchas IsaacBoard member · Jul 7, 2026Sold 16,906 sharesabout $409 thousand · pre-planned
  • Barchas IsaacBoard member · Jul 6, 2026Sold 83,094 sharesabout $2.0 million · pre-planned
  • Lechleider RobertChief Medical Officer · Jul 2, 2026Sold 22,714 sharesabout $499 thousand · pre-planned
  • Lechleider RobertChief Medical Officer · Jul 2, 2026Sold 16,214 sharesabout $369 thousand · pre-planned
  • Lechleider RobertChief Medical Officer · Jul 2, 2026Sold 16,072 sharesabout $377 thousand · pre-planned
  • Barchas IsaacBoard member · Jul 2, 2026Sold 75,665 sharesabout $1.7 million · pre-planned
  • Barchas IsaacBoard member · Jul 2, 2026Sold 24,335 sharesabout $568 thousand · pre-planned
  • Barchas IsaacBoard member · Jun 30, 2026Sold 101,050 sharesabout $2.1 million · pre-planned
  • Lechleider RobertChief Medical Officer · Jun 25, 2026Sold 40,580 sharesabout $794 thousand · pre-planned
  • Lechleider RobertChief Medical Officer · Jun 25, 2026Sold 14,420 sharesabout $298 thousand · pre-planned
  • Rosett MaxChief Financial Officer · Jun 15, 2026Sold 60,000 sharesabout $1.1 million · pre-planned
  • BIENAIME JEAN JACQUESBoard member · Jun 5, 2026Sold 500 sharesabout $10 thousand · not pre-planned
  • BIENAIME JEAN JACQUESBoard member · Jun 5, 2026Sold 10,000 sharesabout $194 thousand · not pre-planned
  • BIENAIME JEAN JACQUESBoard member · Jun 5, 2026Bought 6,000 sharesabout $117 thousand ·
  • BIENAIME JEAN JACQUESBoard member · Jun 5, 2026Bought 3,500 sharesabout $68 thousand ·
  • BIENAIME JEAN JACQUESBoard member · Jun 5, 2026Bought 1,000 sharesabout $19 thousand ·
  • BIENAIME JEAN JACQUESBoard member · May 15, 2026Bought 5,000 sharesabout $104 thousand ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Signed a major agreementNews report (8-K)Oct 5, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 11, 2026
  • Shared quarterly resultsNews report (8-K)Aug 11, 2026
  • News reportNews report (8-K)Jun 12, 2026
  • Quarterly reportQuarterly report (10-Q)May 12, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Shared quarterly resultsNews report (8-K)
May 12, 2026